169 related articles for article (PubMed ID: 29993134)
1. Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of α-synuclein in multiple system atrophy.
Kiely AP; Miners JS; Courtney R; Strand C; Love S; Holton JL
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):347-360. PubMed ID: 29993134
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1.
Miners JS; Renfrew R; Swirski M; Love S
Acta Neuropathol Commun; 2014 Dec; 2():164. PubMed ID: 25476568
[TBL] [Abstract][Full Text] [Related]
3. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
[TBL] [Abstract][Full Text] [Related]
5. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
Donadio V; Incensi A; Rizzo G; Westermark GT; Devigili G; De Micco R; Tessitore A; Nyholm D; Parisini S; Nyman D; Tedeschi G; Eleopra R; Ingelsson M; Liguori R
Brain; 2023 Mar; 146(3):1065-1074. PubMed ID: 35552610
[TBL] [Abstract][Full Text] [Related]
9. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
[TBL] [Abstract][Full Text] [Related]
10. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
[TBL] [Abstract][Full Text] [Related]
12. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
[TBL] [Abstract][Full Text] [Related]
13. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
14. Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.
Donadio V; Incensi A; El-Agnaf O; Rizzo G; Vaikath N; Del Sorbo F; Scaglione C; Capellari S; Elia A; Stanzani Maserati M; Pantieri R; Liguori R
Sci Rep; 2018 Sep; 8(1):14246. PubMed ID: 30250046
[TBL] [Abstract][Full Text] [Related]
15. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
[TBL] [Abstract][Full Text] [Related]
16. Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy.
Ayers JI; Lee J; Monteiro O; Woerman AL; Lazar AA; Condello C; Paras NA; Prusiner SB
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115402
[TBL] [Abstract][Full Text] [Related]
17. A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.
Spencer B; Valera E; Rockenstein E; Trejo-Morales M; Adame A; Masliah E
Mol Neurodegener; 2015 Sep; 10():48. PubMed ID: 26394760
[TBL] [Abstract][Full Text] [Related]
18. Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy.
Sevenich M; Honold D; Willuweit A; Kutzsche J; Mohrlüder J; Willbold D
Neurochem Int; 2022 Dec; 161():105422. PubMed ID: 36252819
[TBL] [Abstract][Full Text] [Related]
19. The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease.
Campbell BC; McLean CA; Culvenor JG; Gai WP; Blumbergs PC; Jäkälä P; Beyreuther K; Masters CL; Li QX
J Neurochem; 2001 Jan; 76(1):87-96. PubMed ID: 11145981
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
